Compare Toronto-Dominion Bank (TD) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Toronto-Dominion Bank vs Zoetis Inc — how do they compare? Toronto-Dominion Bank trades at $115.1 (market cap $185.79B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Toronto-Dominion Bank is far larger — about 6.2× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Toronto-Dominion Bank for 84 Days and Zoetis Inc for 70 Days on average.
| TD | ZTS | |
|---|---|---|
Market Cap | $185.79B | $30.20B |
Volume | 3,263,867 | 6,175,327 |
Sector | Financials | Health |
52-Week High | $124.80 | $147.53 |
52-Week Low | $78.32 | $69.09 |
Typical Hold Time | 84 Days | 70 Days |
Enterprise Value | $559.06B | $37.76B |
Dividend Yield | 2.84% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TD Bank trades at $114.04, up 0.15% with a P/E of 17.36 and strong profitability metrics including 24.88% net income margin. Recent earnings have consistently beaten expectations, with three consecutive quarterly beats. Technical indicators show bearish momentum despite oversold RSI readings. The company announced a $10 billion share buyback program and $108 billion Canadian infrastructure commitment, signaling confidence in future growth.
The outlook remains positive with analyst consensus favoring Buy ratings (52.94%) and strong fundamentals, though technical weakness and increasing debt-to-asset ratios present near-term challenges. Revenue growth trajectory from $61.3B to projected $65.1B supports long-term investment case, while volatile cash flows require monitoring.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
